Dow Down 0.02% Nasdaq Up 0.07%

Alkermes plc (ALKS)

-NasdaqGS
54.17 Down 1.73(3.09%) 4:00PM EST
|After Hours : 54.16 Down 0.01 (0.02%) 4:31PM EST
Prev Close:55.90
Open:56.25
Bid:N/A
Ask:56.12 x 500
1y Target Est:50.83
Beta:1.94
Next Earnings Date:N/A
Day's Range:53.36 - 56.25
52wk Range:38.26 - 56.59
Volume:1,186,078
Avg Vol (3m):876,943
Market Cap:7.92B
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSDown 3.09%7.92B
ABTDown 0.36%66.50B
LLYDown 0.12%71.50B
GSKUp 0.02%111.26B

Key Statistics

Forward P/E (1 yr):180.57
P/S (ttm):14.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.27
Quarterly EPS Est (Dec-14) :0.03
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):6.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback